Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.6 SEK | +1.65% | -0.69% | +39.72% |
05-08 | Transcript : Orexo AB, Q1 2024 Earnings Call, May 08, 2024 | |
04-17 | Orexo Expands, Extends US Patent for Nasal Anaphylaxis Treatment | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+39.72% | 69.42M | |
+16.93% | 79.28B | |
+7.97% | 8.74B | |
-17.73% | 4.84B | |
+56.03% | 4.74B | |
+1.31% | 3.87B | |
+18.99% | 2.46B | |
-25.43% | 2.18B | |
+14.61% | 2.09B | |
-37.31% | 1.98B |
- Stock Market
- Equities
- ORX Stock
- News Orexo AB
- Transcript : Orexo AB, Q4 2021 Earnings Call, Jan 27, 2022